Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2010 Nov 1;30(7):1843–1856. doi: 10.1148/rg.307105063

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© RSNA, 2010

PMC Copyright notice

Figure 13a — Hematoma in a 75-year-old woman who had undergone chemotherapy–radiation therapy for stage IIB cervical carcinoma. (a) Sagittal T2-weighted MR image shows a frondlike abnormality at the base of the bladder (arrow) consistent with a hematoma. However, transitional cell carcinoma of the bladder can also have a frondlike appearance, and biopsy is required to distinguish between a hematoma and a malignant process. (b) Axial T1-weighted MR image shows increased signal intensity within the clot (arrow), a finding that represents hemorrhage.

Figure 13b — Hematoma in a 75-year-old woman who had undergone chemotherapy–radiation therapy for stage IIB cervical carcinoma. (a) Sagittal T2-weighted MR image shows a frondlike abnormality at the base of the bladder (arrow) consistent with a hematoma. However, transitional cell carcinoma of the bladder can also have a frondlike appearance, and biopsy is required to distinguish between a hematoma and a malignant process. (b) Axial T1-weighted MR image shows increased signal intensity within the clot (arrow), a finding that represents hemorrhage.